Shin Nippon Biomedical Laboratories, Ltd. (2395.T)
JPY 1537.0
(-1.22%)
JPY 1537.0
(-1.22%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 8.98 Billion JPY | -44.78% |
| 2022 | 9.48 Billion JPY | 25.45% |
| 2021 | 9.48 Billion JPY | 73.47% |
| 2020 | 5.54 Billion JPY | 18.32% |
| 2019 | 4.52 Billion JPY | 23.88% |
| 2018 | 3.39 Billion JPY | 192.55% |
| 2017 | 338.82 Million JPY | 122.5% |
| 2016 | 1.15 Billion JPY | -83.98% |
| 2015 | 5.44 Billion JPY | 78.64% |
| 2014 | 1.28 Billion JPY | 3.77% |
| 2013 | 1.72 Billion JPY | 49.2% |
| 2012 | 1.16 Billion JPY | 843.33% |
| 2011 | -959.74 Million JPY | -109.58% |
| 2010 | 967.89 Million JPY | -52.0% |
| 2009 | 2.69 Billion JPY | 10.8% |
| 2008 | 2.31 Billion JPY | -23.09% |
| 2007 | 2.92 Billion JPY | 25.31% |
| 2006 | 2.45 Billion JPY | 33.53% |
| 2005 | 1.67 Billion JPY | 114.23% |
| 2004 | 495 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 321.8 Million JPY | -87.7% |
| 2023 Q1 | 1.91 Billion JPY | -18.49% |
| 2023 Q2 | 1.9 Billion JPY | -0.5% |
| 2023 Q3 | 1.16 Billion JPY | -39.0% |
| 2023 Q4 | 2.16 Billion JPY | 86.27% |
| 2023 FY | - JPY | -44.78% |
| 2022 Q1 | 2.8 Billion JPY | 15.63% |
| 2022 Q3 | 987.12 Million JPY | -68.98% |
| 2022 Q4 | 2.34 Billion JPY | 137.92% |
| 2022 FY | - JPY | 25.45% |
| 2022 Q2 | 3.18 Billion JPY | 13.62% |
| 2021 Q2 | 1.89 Billion JPY | 83.4% |
| 2021 FY | - JPY | 73.47% |
| 2021 Q1 | 1.03 Billion JPY | -49.46% |
| 2021 Q3 | 2.18 Billion JPY | 15.54% |
| 2021 Q4 | 2.42 Billion JPY | 10.91% |
| 2020 Q1 | 784.18 Million JPY | -24.16% |
| 2020 FY | - JPY | 18.32% |
| 2020 Q4 | 2.03 Billion JPY | 430.47% |
| 2020 Q2 | 622.19 Million JPY | -20.66% |
| 2020 Q3 | 384.44 Million JPY | -38.21% |
| 2019 Q1 | 100 Million JPY | -87.14% |
| 2019 Q2 | 937.83 Million JPY | 837.77% |
| 2019 Q3 | 939.74 Million JPY | 0.2% |
| 2019 FY | - JPY | 23.88% |
| 2019 Q4 | 1.03 Billion JPY | 10.03% |
| 2018 Q2 | 418.3 Million JPY | -35.67% |
| 2018 Q3 | 215.5 Million JPY | -48.48% |
| 2018 Q4 | 777.49 Million JPY | 260.78% |
| 2018 FY | - JPY | 192.55% |
| 2018 Q1 | 650.23 Million JPY | 228.95% |
| 2017 Q4 | 197.66 Million JPY | 445.23% |
| 2017 Q3 | -57.25 Million JPY | -277.86% |
| 2017 Q2 | 32.19 Million JPY | 106.77% |
| 2017 FY | - JPY | 122.5% |
| 2017 Q1 | -475.29 Million JPY | -177.96% |
| 2016 FY | - JPY | -83.98% |
| 2016 Q2 | -999.52 Million JPY | 41.91% |
| 2016 Q3 | 1.09 Billion JPY | 209.12% |
| 2016 Q4 | 609.68 Million JPY | -44.1% |
| 2016 Q1 | -1.72 Billion JPY | -29.37% |
| 2015 Q3 | 2.68 Billion JPY | 281.22% |
| 2015 Q2 | -1.47 Billion JPY | -181.35% |
| 2015 Q1 | 1.81 Billion JPY | 1110.87% |
| 2015 FY | - JPY | 78.64% |
| 2015 Q4 | -1.33 Billion JPY | -149.61% |
| 2014 Q4 | 150.19 Million JPY | -77.79% |
| 2014 FY | - JPY | 3.77% |
| 2014 Q3 | 676.19 Million JPY | 252.91% |
| 2014 Q2 | 191.6 Million JPY | 133.47% |
| 2014 Q1 | -572.46 Million JPY | -177.78% |
| 2013 Q2 | -557.82 Million JPY | -1914.3% |
| 2013 Q1 | -27.69 Million JPY | -119.05% |
| 2013 Q3 | 301.79 Million JPY | 154.1% |
| 2013 FY | - JPY | 49.2% |
| 2013 Q4 | 736.02 Million JPY | 143.88% |
| 2012 Q2 | -507.07 Million JPY | -34.5% |
| 2012 Q3 | 550.85 Million JPY | 208.63% |
| 2012 FY | - JPY | 843.33% |
| 2012 Q1 | -377.02 Million JPY | -48.81% |
| 2012 Q4 | 145.37 Million JPY | -73.61% |
| 2011 FY | - JPY | -109.58% |
| 2011 Q4 | -253.36 Million JPY | -5.48% |
| 2011 Q3 | -240.2 Million JPY | 69.99% |
| 2011 Q2 | -800.55 Million JPY | -74.63% |
| 2011 Q1 | -458.43 Million JPY | -133.81% |
| 2010 Q4 | 1.35 Billion JPY | 316.23% |
| 2010 Q3 | 325.73 Million JPY | 807.33% |
| 2010 Q1 | -50.05 Million JPY | -103.42% |
| 2010 FY | - JPY | -52.0% |
| 2010 Q2 | 35.9 Million JPY | 171.72% |
| 2009 Q3 | 582.28 Million JPY | -2.67% |
| 2009 Q4 | 1.46 Billion JPY | 151.56% |
| 2009 FY | - JPY | 10.8% |
| 2009 Q1 | 828.46 Million JPY | -51.8% |
| 2009 Q2 | 598.25 Million JPY | -27.79% |
| 2008 Q3 | -238.12 Million JPY | -1220.58% |
| 2008 FY | - JPY | -23.09% |
| 2008 Q4 | 1.71 Billion JPY | 821.8% |
| 2008 Q2 | 21.25 Million JPY | 0.0% |
| 2007 FY | - JPY | 25.31% |
| 2006 FY | - JPY | 33.53% |
| 2005 FY | - JPY | 114.23% |
| 2004 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| DNA Chip Research Inc. | -217 Million JPY | 4238.808% |
| Cosmo Bio Company,Limited | 669 Million JPY | -1242.483% |
| H.U. Group Holdings, Inc. | 13.64 Billion JPY | 34.189% |
| FALCO HOLDINGS Co., Ltd. | 3.13 Billion JPY | -186.756% |
| BML, Inc. | 16.41 Billion JPY | 45.3% |
| Human Metabolome Technologies, Inc. | 306.48 Million JPY | -2830.402% |
| Precision System Science Co., Ltd. | -661.75 Million JPY | 1457.191% |